Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Monday 8 August 2016

High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma.

Stephen Opat et al. published in the British Journal of Haematology.

Read article here.

No comments:

Post a Comment